Systemic Metabolomic Profiling of Acute Myeloid Leukemia Patients before and During Disease-Stabilizing Treatment Based on All-Trans Retinoic Acid, Valproic Acid, and Low-Dose Chemotherapy

by Cyrus Huneycutt | Nov 26, 2023 | 0 comments

Submit a Comment Cancel reply

You must be logged in to post a comment.